Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SO-YOUNG INTERNATIONAL INC.

(SY)
  Report
Delayed Nasdaq  -  04:00 2022-09-23 pm EDT
0.7350 USD   -2.00%
09/15SO YOUNG INTERNATIONAL : Appointment of Management Positions - Form 6-K
PU
09/15So-Young International Inc. Announces Appointment of Management Positions
CI
08/22Asian ADRs Move Lower in Monday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

So-Young Reports Unaudited Second Quarter 2022 Financial Results

08/16/2022 | 05:31am EDT

BEIJING, Aug. 16, 2022 (GLOBE NEWSWIRE) -- So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the second quarter ended June 30, 2022.

Second Quarter 2022 Financial Highlights

  • Total revenues were RMB309.1 million (US$46.1 million1), a decrease of 31.6% from RMB451.8 million in the same period of 2021.

  • Net loss attributable to So-Young International Inc. was RMB32.3 million (US$4.8 million), compared with net income attributable to So-Young International Inc. of RMB57.6 million in the second quarter of 2021.

  • Non-GAAP net loss attributable to So-Young International Inc.2 was RMB22.7 million (US$3.4 million), compared with non-GAAP net income attributable to So-Young International Inc. of RMB73.7 million in the same period of 2021.

Second Quarter 2022 Operational Highlights

  • Average mobile MAUs were 3.5 million, compared with 10.0 million in the second quarter of 2021.

  • Number of paying medical service providers on So-Young’s platform were 5,735, an increase of 17.1% from 4,899 in the second quarter of 2021.

  • Number of medical service providers subscribing to information services on So-Young’s platform were 2,622, compared with 2,236 in the second quarter of 2021.

  • Total number of purchasing users through reservation services were 129.5 thousand and the aggregate value of medical aesthetic treatment transactions facilitated by So-Young’s platform was RMB353.1 million.

Mr. Xing Jin, Co-Founder and Chief Executive Officer of So-Young, commented, “In this quarter, we recorded a solid result, which also demonstrated our resilience amid COVID-19 resurgence and soft consumer sentiment. Benefiting from our digital capabilities and innovative user experience, the number of paying medical service providers on So-Young’s platform increased by 17.1% year-over-year to 5,735.”

Mr. Jin continued, “In the current challenging environment, our business remained on track, and we are also refining our infrastructure capacity. Recently, we launched “So-Young Select” strategy to help medical service providers improve operating efficiency and support users in making better decisions. Looking ahead, we are committed to having a healthy growth strategy and create more value to reaffirm our leadership position.”

Mr. Min Yu, Chief Financial Officer of So-Young, commented, “We are encouraged to see a gradual recovery and a steady increase quarter-over-quarter on the top line. Meanwhile, we were prudent with our expenses management and narrowed our loss in the quarter. As a result, the non-GAAP net loss attributable to So-Young International Inc. narrowed by more than 53.0% quarter-over-quarter. Going forward, we will continue to execute our business strategies and keep a healthy cash reserve with RMB1,598.9 million as of June 30, 2022 to generate long-term shareholder value.”

Second Quarter 2022 Financial Results

Revenues

Total revenues were RMB309.1 million (US$46.1 million), a decrease of 31.6% from RMB451.8 million in the same period of 2021. The decrease was primarily due to a decrease in average revenue per paying medical service provider which was impacted by the resurgence of COVID-19 and the weakening macro-economic environment.

  • Information services and other revenues were RMB219.3 million (US$32.7 million), a decrease of 39.2% from RMB360.7 million in the same period of 2021. The decrease was primarily due to a decrease in average revenue per paying medical service provider subscribing to information services.

  • Reservation services revenues were RMB30.6 million (US$4.6 million), a decrease of 66.4% from RMB91.1 million in the same period of 2021.The decrease was primarily due to the impact by the resurgence of COVID-19 in certain cities in China and adoption of new operating strategy which gave higher subsidies to end users.

  • Sales of equipment and maintenance services revenues were RMB59.1 million (US$8.8 million), from Wuhan Miracle Laser Systems, Inc. (“Wuhan Miracle”).

Cost of Revenues

Cost of revenues were RMB104.5 million (US$15.6 million), an increase of 77.7% from RMB58.8 million in the second quarter of 2021. The increase was primarily due to the consolidation of Wuhan Miracle. Cost of revenues included share-based compensation expenses of RMB2.7 million (US$0.4 million) during the second quarter of 2022, compared with RMB3.8 million in the corresponding period of 2021.

Operating Expenses

Total operating expenses were RMB246.6 million (US$36.8 million), a decrease of 26.5% from RMB335.4 million in the second quarter of 2021.

  • Sales and marketing expenses were RMB121.7 million (US$18.2 million), a decrease of 41.1% from RMB206.7 million in the second quarter of 2021. The decrease was primarily due to a decrease in expenses associated with branding and user acquisition activities. Sales and marketing expenses for the second quarter of 2022 included share-based compensation expenses of RMB2.2 million (US$0.3 million), compared with RMB1.6 million in the corresponding period of 2021.

  • General and administrative expenses were RMB61.8 million (US$9.2 million), an increase of 9.4% from RMB56.5 million in the second quarter of 2021. The increase was primarily due to the consolidation of Wuhan Miracle and the increase of professional services fee. General and administrative expenses for the second quarter of 2022 included share-based compensation expenses of RMB2.2 million (US$0.3 million), compared with RMB7.2 million in the corresponding period of 2021.

  • Research and development expenses were RMB63.1 million (US$9.4 million), a decrease of 12.5% from RMB72.1 million in the second quarter of 2021. The decrease was primarily attributable to a decrease in payroll costs associated with the employee headcount. Research and development expenses for the second quarter of 2022 included share-based compensation expenses of RMB2.5 million (US$0.4 million), compared with RMB3.6 million in the corresponding period of 2021.

Income tax (expenses)/benefit

Income tax benefit was RMB0.1 million (US$0.0 million), compared with income tax expenses of RMB11.1 million in the same period of 2021.

Net income/(loss) attributable to So-Young International Inc.

Net loss attributable to So-Young International Inc. was RMB32.3 million (US$4.8 million), compared with a net income attributable to So-Young International Inc. of RMB57.6 million in the second quarter of 2021.

Non-GAAP Net income/(loss) attributable to So-Young International Inc.

Non-GAAP net loss attributable to So-Young International Inc., which excludes the impact of share-based compensation expenses, was RMB22.7 million (US$3.4 million), compared with RMB73.7 million non-GAAP net income attributable to So-Young International Inc. in the same period of 2021.

Basic and Diluted Earnings/(loss) per ADS

Basic and diluted loss per ADS attributable to ordinary shareholders were RMB0.30 (US$0.04) and RMB0.30 (US$0.04), respectively, compared with basic and diluted earnings per ADS attributable to ordinary shareholders of RMB0.54 and RMB0.53, respectively, in the same period of 2021.

Cash and Cash Equivalents, Restricted Cash and Term Deposits, Term Deposits and Short-Term Investments

As of June 30, 2022, cash and cash equivalents, restricted cash and term deposits, term deposits and short-term investments were RMB1,598.9 million (US$238.7 million), compared with RMB1,756.0 million as of December 31, 2021.

Business Outlook

For the third quarter of 2022, So-Young expects total revenues to be between RMB310 million (US$46.3 million) and RMB330 million (US$49.3 million), representing a 28.1% to 23.5% decrease from the same period in 2021. The above outlook is based on the current market conditions and reflects the Company’s preliminary estimates of market and operating conditions, as well as customer demand, which are all subjected to change, particularly in view of the potential impact of the COVID-19, the effects of which are difficult to analyze and predict.

Non-GAAP Financial Measures

To supplement the financial measures prepared in accordance with generally accepted accounting principles in the United States, or GAAP, this press release presents non-GAAP (loss)/income from operations and non-GAAP net (loss)/income attributable to So-Young International Inc. by excluding share-based compensation expenses from (loss)/income from operations and net (loss)/income attributable to So-Young International Inc., respectively. The Company believes these non-GAAP financial measures are important to help investors understand the Company’s operating and financial performance, compare business trends among different reporting periods on a consistent basis and assess the Company’s core operating results, as they exclude certain expenses that are not expected to result in cash payments. The use of the above non-GAAP financial measures has certain limitations. Share-based compensation expenses have been and will continue to be incurred in the future. This is not reflected in the presentation of the non-GAAP financial measures, but should be considered in the overall evaluation of the Company’s results. The Company compensates for these limitations by providing the relevant disclosure of its share-based compensation expenses in the reconciliations to the most directly comparable GAAP financial measures, which should be considered when evaluating the Company’s performance. These non-GAAP financial measures should be considered in addition to financial measures prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP. Reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measure is set forth at the end of this release.

Conference Call Information
So-Young’s management will hold an earnings conference call on Tuesday, August 16, 2022, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Participants can register for the conference call by navigating to https://s1.c-conf.com/DiamondPass/10024340-hd864t.html.

Once preregistration has been completed, participants will receive dial-in numbers, an event passcode, and a unique registrant ID.

To join the conference, please dial the number you receive, enter the event passcode followed by your unique registrant ID, and you will be joined to the conference instantly.

A telephone replay will be available two hours after the conclusion of the conference call until midnight U.S. Eastern Time, August 23, 2022. The dial-in details are:

International:+61 7 3107 6325
US:+1855 883 1031
Passcode:10024340

Additionally, a live and archived webcast of this conference call will be available at http://ir.soyoung.com.

About So-Young International Inc.
So-Young International Inc. (Nasdaq: SY) (“So-Young” or the “Company”) is the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry. The Company presents users with reliable information through offering high quality and trustworthy content together with a multitude of social functions on its platform, as well as by curating medical aesthetic service providers that are carefully selected and vetted. Leveraging So-Young’s strong brand image, extensive audience reach, trust from its users, highly engaging social community and data insights, the Company is well-positioned to expand both along the medical aesthetic industry value chain and into the massive, fast-growing consumption healthcare service market.

Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Among other things, the Financial Guidance and quotations from management in this announcement, as well as So-Young’s strategic and operational plans, contain forward-looking statements. So-Young may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to fourth parties. Statements that are not historical facts, including but not limited to statements about So-Young’s beliefs and expectations, are forward-looking statements. Forward looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: So-Young’s strategies; So-Young’s future business development, financial condition and results of operations; So-Young’s ability to retain and increase the number of users and medical service providers, and expand its service offerings; competition in the online medical aesthetic service industry; changes in So-Young’s revenues, costs or expenditures; Chinese governmental policies and regulations relating to the online medical aesthetic service industry, general economic and business conditions globally and in China; the impact of the COVID-19 pandemic to So-Young’s business operations and the economy in China and elsewhere generally; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company’s filings with the Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of the press release, and So-Young undertakes no duty to update such information, except as required under applicable law.

For more information, please contact:

So-Young

Investor Relations
Ms. Vivian Xu
Phone: +86-10-8790-2012
E-mail: ir@soyoung.com

Christensen

In China
Mr. Eric Yuan
Phone: +86-10-5900-1548
E-mail: Eyuan@christensenir.com

In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: lbergkamp@christensenir.com

SO-YOUNG INTERNATIONAL INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands, except for share and per share data)
 
 As of
 December 31, June 30, June 30,
202120222022
 RMB RMB US$
Assets     
Current assets:     
Cash and cash equivalents1,331,968 1,471,756 219,727
Restricted cash and term deposits15,119 16,504 2,464
Trade receivables54,829 40,686 6,074
Inventories, net91,812 94,614 14,125
Receivables from online payment platforms18,864 15,760 2,353
Amounts due from related parties14,038 28,502 4,255
Term deposits and short-term investments408,946 110,592 16,511
Prepayment and other current assets91,842 127,079 18,972
Total current assets2,027,418 1,905,493   284,481
Non-current assets:     
Long-term investments252,500 250,988 37,472
Intangible assets193,955 181,881 27,154
Goodwill540,693 540,693 80,723
Property and equipment, net124,576 120,433 17,980
Deferred tax assets47,520 47,882 7,149
Operating lease right-of-use assets95,609 82,667 12,342
Other non-current assets48,097 105,828 15,800
Total non-current assets1,302,950  1,330,372   198,620
Total assets3,330,368 3,235,865  483,101
      
Liabilities     
Current liabilities:     
Taxes payable48,571 51,866 7,743
Contract liabilities139,155 127,415 19,023
Salary and welfare payables103,624 75,268 11,237
Amounts due to related parties681 47 7
Accrued expenses and other current liabilities376,841 354,381 52,906
Operating lease liabilities-current43,529 52,341 7,814
Total current liabilities712,401 661,318  98,730
Non-current liabilities:     
Operating lease liabilities-non current62,356 42,735 6,380
Deferred tax liabilities38,577 35,478 5,297
Total non-current liabilities100,933  78,213 11,677
Total liabilities813,334  739,531  110,407
      


SO-YOUNG INTERNATIONAL INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Continued)
(Amounts in thousands, except for share and per share data)
 
Shareholders’ equity:     
Treasury stock(217,712) (217,712) (32,504)
Class A Ordinary shares (US$ 0.0005 par value; 750,000,000 shares authorized as of December 31, 2021 and June 30, 2022; 71,736,059 and 69,092,367 shares issued and outstanding as of December 31, 2021, 72,060,295 and 69,416,603 shares issued and outstanding as of June 30, 2022, respectively)230  232  34 
Class B Ordinary shares (US$ 0.0005 par value; 20,000,000 shares authorized as of December 31, 2021 and June 30, 2022; 12,000,000 shares issued and outstanding as of December 31, 2021 and June 30, 2022)37  37  6 
Additional paid-in capital2,999,562  3,028,134  452,089 
Statutory reserves20,331  20,331  3,035 
Accumulated deficit(272,368) (371,505) (55,464)
Accumulated other comprehensive loss(83,891) (33,505) (5,002)
Total So-Young International Inc. shareholders’ equity2,446,189  2,426,012  362,194 
      
Non-controlling interests70,845  70,322  10,500 
      
Total shareholders’ equity2,517,034  2,496,334  372,694 
      
Total liabilities and shareholders’ equity3,330,368  3,235,865  483,101 
         


SO-YOUNG INTERNATIONAL INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except for share and per share data)
 
 
 For the Three Months Ended For the Six Months Ended
 June 30,
2021
 June 30,
2022
 June 30,
2022
 June 30,
2021
 June 30,
2022
 June 30,
2022
 RMB RMB US$ RMB RMB US$
            
Revenues           
Information services and others360,714  219,343  32,747  638,547  418,874  62,536 
Reservation services91,131  30,616  4,571  172,943  72,969  10,894 
Sales of equipment and maintenance services-  59,120  8,827  -  117,582  17,555 
Total revenues451,845  309,079  46,145  811,490  609,425  90,985 
Cost of revenues(58,807) (104,479) (15,598) (111,161) (211,062) (31,511)
Gross profit393,038  204,600  30,547  700,329  398,363  59,474 
Operating expenses:           
Sales and marketing expenses(206,730) (121,740) (18,175) (449,088) (248,953) (37,169)
General and administrative expenses(56,494) (61,794) (9,226) (111,671) (127,186) (18,988)
Research and development expenses(72,132) (63,089) (9,419) (141,935) (142,023) (21,203)
Total operating expenses(335,356) (246,623) (36,820) (702,694) (518,162) (77,360)
Income/(loss) from operations57,682  (42,023) (6,273) (2,365) (119,799) (17,886)
Other income/(expenses):           
Investment income3,064  1,068  159  5,732  3,504  523 
Interest income4,771  5,347  798  10,771  8,546  1,276 
Exchange gains/(losses)358  (600) (90) (4,353) (539) (80)
Share of income/(losses) of equity method investee54  (833) (124) 133  (1,902) (284)
Others, net1,499  4,425  661  6,904  8,381  1,251 
Income/(Loss) before tax67,428  (32,616) (4,869) 16,822  (101,809) (15,200)
Income tax (expenses)/benefit(11,122) 55  8  (6,788) 2,056  307 
Net income/(loss)56,306  (32,561) (4,861) 10,034  (99,753) (14,893)
Net loss attributable to noncontrolling interests1,288  265  40  2,563  616  92 
Net income/(loss) attributable to So-Young International Inc.57,594  (32,296) (4,821) 12,597  (99,137) (14,801)
                  


SO-YOUNG INTERNATIONAL INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Continued)
(Amounts in thousands, except for share and per share data)
 
 For the Three Months Ended For the Six Months Ended 
 June 30, 2021 June 30, 2022 June 30, 2022 June 30, 2021 June 30, 2022 June 30, 2022
 RMB RMB US$ RMB RMB US$
            
Net income/(loss) per ordinary share           
Net earnings/(loss) per ordinary share attributable to ordinary shareholder - basic0.70  (0.39) (0.06) 0.15  (1.20) (0.18)
Net earnings/(loss) per ordinary share attributable to ordinary shareholder - diluted0.69  (0.39) (0.06) 0.15  (1.20) (0.18)
Net earnings/(loss) per ADS attributable to ordinary shareholders - basic (13 ADS represents 10 Class A ordinary shares)0.54  (0.30) (0.04) 0.12  (0.92) (0.14)
Net earnings/(loss) per ADS attributable to ordinary shareholders - diluted (13 ADS represents 10 Class A ordinary shares)0.53  (0.30) (0.04) 0.12  (0.92) (0.14)
Weighted average number of ordinary shares used in computing earnings/(loss) per share, basic*82,403,282  82,709,017  82,709,017  82,260,972  82,394,496  82,394,496 
Weighted average number of ordinary shares used in computing earnings/(loss) per share, diluted*83,023,318  82,709,017  82,709,017  83,695,653  82,394,496  82,394,496 
            
Share-based compensation expenses included in:           
Cost of revenues(3,791) (2,662) (397) (8,124) (5,296) (791)
Sales and marketing expenses(1,550) (2,236) (334) (3,844) (5,672) (847)
General and administrative expenses(7,246) (2,249) (336) (14,414) (10,163) (1,517)
Research and development expenses(3,564) (2,478) (370) (8,680) (7,070) (1,056)
                  
* Both Class A and Class B ordinary shares are included in the calculation of the weighted average number of ordinary shares outstanding, basic and diluted.


SO-YOUNG INTERNATIONAL INC.
Reconciliation of GAAP and Non-GAAP Results
(Amounts in thousands, except for share and per share data)
 
 For the Three Months Ended For the Six Months Ended
 June 30,
2021
 June 30,
2022
 June 30,
2022
 June 30,
2021
 June 30,
2022
 June 30,
2022
 RMB RMB US$ RMB RMB US$
            
GAAP Income/(loss) from operations57,682 (42,023) (6,273) (2,365) (119,799) (17,886)
Add back: Share-based compensation expenses16,151 9,625  1,437  35,062  28,201  4,211 
Non-GAAP Income/(loss) from operations73,833 (32,398) (4,836) 32,697  (91,598) (13,675)
            
            
GAAP Net income/(loss) attributable to So-Young International Inc.57,594 (32,296) (4,821) 12,597  (99,137) (14,801)
Add back: Share-based compensation expenses16,151 9,625  1,437  35,062  28,201  4,211 
Non-GAAP Net income/(loss) attributable to So-Young International Inc.73,745 (22,671) (3,384) 47,659  (70,936) (10,590)
                 

 

_______________________

1 This press release contains translations of certain Renminbi (RMB) amounts into U.S. dollars (US$) solely for the convenience of the reader. Unless otherwise specified, all translations of Renminbi amounts into U.S. dollar amounts in this press release are made at RMB6.6981 to US$1.00, which was the U.S. dollars middle rate announced by the Board of Governors of the Federal Reserve System of the United States on June 30, 2022.

2 Non-GAAP net loss attributable to So-Young International Inc. is defined as net loss attributable to So-Young International Inc. excluding share-based compensation expenses. See “Reconciliation of GAAP and Non-GAAP Results” at the end of this press release.

 


All news about SO-YOUNG INTERNATIONAL INC.
09/15SO YOUNG INTERNATIONAL : Appointment of Management Positions - Form 6-K
PU
09/15So-Young International Inc. Announces Appointment of Management Positions
CI
08/22Asian ADRs Move Lower in Monday Trading
MT
08/16SO YOUNG INTERNATIONAL : Young Reports Unaudited Second Quarter 2022 Financial Results - F..
PU
08/16So-Young International Inc. Reports Earnings Results for the Second Quarter and Six Mon..
CI
08/16TRANSCRIPT : So-Young International Inc., Q2 2022 Earnings Call, Aug 16, 2022
CI
08/16Earnings Flash (SY) SO-YOUNG INTERNATIONAL Posts Q2 Loss $-0.04
MT
08/16So-Young Reports Unaudited Second Quarter 2022 Financial Results
GL
08/16So-Young International Inc. Provides Revenue Guidance for the Third Quarter of 2022
CI
08/09So-Young to Report Second Quarter 2022 Financial Results on August 16, 2022
GL
More news
Analyst Recommendations on SO-YOUNG INTERNATIONAL INC.
More recommendations
Financials
Sales 2022 1 267 M 178 M 178 M
Net income 2022 -108 M -15,2 M -15,2 M
Net Debt 2022 - - -
P/E ratio 2022 -5,19x
Yield 2022 -
Capitalization 554 M 77,8 M 77,8 M
Capi. / Sales 2022 0,44x
Capi. / Sales 2023 0,35x
Nbr of Employees 2 085
Free-Float 50,4%
Chart SO-YOUNG INTERNATIONAL INC.
Duration : Period :
So-Young International Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SO-YOUNG INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 5,24 CNY
Average target price 14,11 CNY
Spread / Average Target 169%
EPS Revisions
Managers and Directors
Xing Jin Chairman, Chief Executive & Operating Officer
Min Yu Chief Financial Officer
Xuejian Li Chief Technology Officer & Director
Zhao Xuan Yang Independent Director
Chao He Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SO-YOUNG INTERNATIONAL INC.-76.96%78
TENCENT HOLDINGS LIMITED-39.80%330 316
NETFLIX, INC.-62.42%100 686
PROSUS N.V.-27.36%71 464
AIRBNB, INC.-38.89%65 069
UBER TECHNOLOGIES, INC.-33.65%55 081